LANIAZID Drug Patent Profile
✉ Email this page to a colleague
When do Laniazid patents expire, and what generic alternatives are available?
Laniazid is a drug marketed by Lannett and Chartwell Molecular and is included in three NDAs.
The generic ingredient in LANIAZID is isoniazid. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Laniazid
A generic version of LANIAZID was approved as isoniazid by OMNIVIUM PHARMS on June 26th, 1997.
Summary for LANIAZID
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 154 |
Patent Applications: | 4,292 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LANIAZID at DailyMed |
Pharmacology for LANIAZID
Drug Class | Antimycobacterial |
Anatomical Therapeutic Chemical (ATC) Classes for LANIAZID
US Patents and Regulatory Information for LANIAZID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lannett | LANIAZID | isoniazid | SYRUP;ORAL | 089243-001 | Feb 3, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chartwell Molecular | LANIAZID | isoniazid | TABLET;ORAL | 089776-001 | Jun 13, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chartwell Molecular | LANIAZID | isoniazid | TABLET;ORAL | 080140-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |